Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in Active Surveillance (AS) patients with recurrent Non-Muscle Invasive Bladder Cancer (NMIBC): Results from the Bladder Cancer Italian Active Surveillance (BIAS) project

Similar Items

• Oncological long-term safety and pathological outcome evaluation for patients under active surveillance for recurrent low-risk non-muscle invasive bladder cancer: Result from bladder cancer Italian active surveillance (BIAS) project
  by: N. Frego, et al.
  Published: (2020-07-01)
• Oncological long-term safety and pathological outcome evaluation for patients under active surveillance for recurrent low-risk non-muscle invasive bladder cancer: result from Bladder Cancer Italian Active Surveillance (BIAS) project
  by: R. Contieri, et al.
  Published: (2020-10-01)
• Head-to-head comparison between micro-ultrasound and MRI in the differentiation between muscle-invasive and non-muscle invasive bladder cancer: Results from the bladder microUS versus MRI cancer imaging staging study (BUS-MISS) protocol
  by: P. Diana, et al.
  Published: (2020-07-01)
• The utility of micro-ultrasound in patients under active surveillance for low-risk prostate cancer: A PRIAS study extension
  by: D. Maffei, et al.
  Published: (2020-07-01)
• Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer
  by: D. Maffei, et al.
  Published: (2020-11-01)